These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 36615764)

  • 1. The Synergistic Protective Effect of γ-Oryzanol (OZ) and N-Acetylcysteine (NAC) against Experimentally Induced NAFLD in Rats Entails Hypoglycemic, Antioxidant, and PPARα Stimulatory Effects.
    Alwadani AH; Almasri SA; Aloud AA; Albadr NA; Alshammari GM; Yahya MA
    Nutrients; 2022 Dec; 15(1):. PubMed ID: 36615764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Esculeogenin A, a Glycan from Tomato, Alleviates Nonalcoholic Fatty Liver Disease in Rats through Hypolipidemic, Antioxidant, and Anti-Inflammatory Effects.
    Al Jadani JM; Albadr NA; Alshammari GM; Almasri SA; Alfayez FF; Yahya MA
    Nutrients; 2023 Nov; 15(22):. PubMed ID: 38004149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of AMPK Entails the Protective Effect of Royal Jelly against High-Fat-Diet-Induced Hyperglycemia, Hyperlipidemia, and Non-Alcoholic Fatty Liver Disease in Rats.
    Felemban AH; Alshammari GM; Yagoub AEA; Al-Harbi LN; Alhussain MH; Yahya MA
    Nutrients; 2023 Mar; 15(6):. PubMed ID: 36986201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The protective effects of the β3 adrenergic receptor agonist BRL37344 against liver steatosis and inflammation in a rat model of high-fat diet-induced nonalcoholic fatty liver disease (NAFLD).
    Wang Z; Li S; Wang R; Guo L; Xu D; Zhang T; Xu Y; Wang W; Wang M; Gan Z; Wang X
    Mol Med; 2020 Jun; 26(1):54. PubMed ID: 32503411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effect of ursodeoxycholic acid, resveratrol, and N-acetylcysteine on nonalcoholic fatty liver disease in rats.
    Ali MH; Messiha BA; Abdel-Latif HA
    Pharm Biol; 2016 Jul; 54(7):1198-208. PubMed ID: 26134756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sesamin ameliorates hepatic steatosis and inflammation in rats on a high-fat diet via LXRα and PPARα.
    Zhang R; Yu Y; Hu S; Zhang J; Yang H; Han B; Cheng Y; Luo X
    Nutr Res; 2016 Sep; 36(9):1022-1030. PubMed ID: 27632923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beneficial effects of neomangiferin on high fat diet-induced nonalcoholic fatty liver disease in rats.
    Zhou C; Zhou J; Han N; Liu Z; Xiao B; Yin J
    Int Immunopharmacol; 2015 Mar; 25(1):218-28. PubMed ID: 25661699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Hepatic Antisteatosis Effect of Xanthohumol in High-Fat Diet-Fed Rats Entails Activation of AMPK as a Possible Protective Mechanism.
    Atteia HH; AlFaris NA; Alshammari GM; Alamri E; Ahmed SF; Albalwi R; Abdel-Sattar SA
    Foods; 2023 Nov; 12(23):. PubMed ID: 38231665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatal ethanol exposure programs an increased susceptibility of non-alcoholic fatty liver disease in female adult offspring rats.
    Shen L; Liu Z; Gong J; Zhang L; Wang L; Magdalou J; Chen L; Wang H
    Toxicol Appl Pharmacol; 2014 Jan; 274(2):263-73. PubMed ID: 24275070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Astaxanthin attenuates hepatic steatosis in high-fat diet-fed rats by suppressing microRNA-21 via transactivation of nuclear factor erythroid 2-related factor 2.
    Shatoor AS; Al Humayed S; Almohiy HM
    J Physiol Biochem; 2022 Feb; 78(1):151-168. PubMed ID: 34651285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The hepatoprotective effects of n3-polyunsaturated fatty acids against non-alcoholic fatty liver disease in diabetic rats through the FOXO1/PPARα/GABARAPL1 signalling pathway.
    Ramadan NM; Elmasry K; Elsayed HRH; El-Mesery A; Eraky SM
    Life Sci; 2022 Dec; 311(Pt A):121145. PubMed ID: 36336129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ascorbic acid inhibits visceral obesity and nonalcoholic fatty liver disease by activating peroxisome proliferator-activated receptor α in high-fat-diet-fed C57BL/6J mice.
    Lee H; Ahn J; Shin SS; Yoon M
    Int J Obes (Lond); 2019 Aug; 43(8):1620-1630. PubMed ID: 30283077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zingerone ameliorates non-alcoholic fatty liver disease in rats by activating AMPK.
    Mohammed HM
    J Food Biochem; 2022 Jul; 46(7):e14149. PubMed ID: 35338494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Water extract from artichoke ameliorates high-fat diet-induced non-alcoholic fatty liver disease in rats.
    Deng A; Liu F; Tang X; Wang Y; Xie P; Yang Q; Xiao B
    BMC Complement Med Ther; 2022 Nov; 22(1):308. PubMed ID: 36424606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exogenous administration of unacylated ghrelin attenuates hepatic steatosis in high-fat diet-fed rats by modulating glucose homeostasis, lipogenesis, oxidative stress, and endoplasmic reticulum stress.
    Alharbi S
    Biomed Pharmacother; 2022 Jul; 151():113095. PubMed ID: 35594708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salidroside inhibits insulin resistance and hepatic steatosis by downregulating miR-21 and subsequent activation of AMPK and upregulation of PPARα in the liver and muscles of high fat diet-fed rats.
    Almohawes ZN; El-Kott A; Morsy K; Shati AA; El-Kenawy AE; Khalifa HS; Elsaid FG; Abd-Lateif AM; Abu-Zaiton A; Ebealy ER; Abdel-Daim MM; Ghanem RA; Abd-Ella EM
    Arch Physiol Biochem; 2024 Jun; 130(3):257-274. PubMed ID: 35061559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eugenol modulates insulin sensitivity by upregulating insulin receptor substrate-2 in non-alcoholic fatty liver disease in rats.
    Fawzy MH; Saeed NM; El-Sherbiny DA; El-Demerdash E
    J Pharm Pharmacol; 2021 Apr; 73(6):846-854. PubMed ID: 33822104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Glucagon-Like Peptide-1 Analogue Liraglutide Inhibits Oxidative Stress and Inflammatory Response in the Liver of Rats with Diet-Induced Non-alcoholic Fatty Liver Disease.
    Gao H; Zeng Z; Zhang H; Zhou X; Guan L; Deng W; Xu L
    Biol Pharm Bull; 2015; 38(5):694-702. PubMed ID: 25947915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention and treatment effect of total flavonoids in Stellera chamaejasme L. on nonalcoholic fatty liver in rats.
    Wang Y; Li JY; Han M; Wang WL; Li YZ
    Lipids Health Dis; 2015 Aug; 14():85. PubMed ID: 26242978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NLRP3 inhibitor glibenclamide attenuates high-fat diet and streptozotocin-induced non-alcoholic fatty liver disease in rat: studies on oxidative stress, inflammation, DNA damage and insulin signalling pathway.
    Dwivedi DK; Jena GB
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Apr; 393(4):705-716. PubMed ID: 31834465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.